[1]Barnard D,Woloski M,Feeny D,et al. Development of disease-specific health-related quality-of-life instruments for children with immune thrombocytopenic purpura and their parents[J]. J Pediatr Hematol Oncol,2003,25(1):56-62.[2]张之南,沈 悌.血液病诊断及疗效标准[M].第3版.北京:科学出版社,2007:172-176.[3]McMillan R.Autoantibodies and autoantigens in chronic immune thrombocytopenic purura[J].Semin Hematol,2000,37(3):239-248.[4]Liblau RS,Singer SM,McDevitt HO. Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases[J]. Immunol Today,1995,16(1):34-38.[5]Nomura S,Yanabu M,Kido H,et al.Significance of cytokines and CD68-positive microparticles in immune thrombocytopenic purpura[J]. Eur J Haematol,1955,55(1):49-56.[6]Braun CM,Huang SK,Bashian GG,et al. Corticosteroid modulation of human,antigen-specific Th1 and Th2 responses[J].J Allergy Clin Immunol,1997,100(3):400-407.[7]Guo C,Chu X,Shi Y,et al.Correction of Th1-dominant cytokine profiles by high-dose dexamethasone in patients with chronic idiopathic thrombocytopenic purpura[J]. J Clin Immunol,2007,27(6):557-562.